Evidence map›Paper›PMID 32843533›Full record

ArticleLife science alliance2020

A dichotomy of gene regulatory associations during the activated B-cell to plasmablast transition.

Mario Cocco, Matthew A Care, Amel Saadi, Muna Al-Maskari, Gina Doody, Reuben Tooze

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Mario CoccoDivision of Immunology and Haematology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.ORCID 0000-0001-6884-5139
Matthew A CareDivision of Immunology and Haematology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.ORCID 0000-0001-6584-5889
Amel SaadiDivision of Immunology and Haematology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
Muna Al-MaskariDivision of Immunology and Haematology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
Gina DoodyDivision of Immunology and Haematology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
Reuben ToozeDivision of Immunology and Haematology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK r.tooze@leeds.ac.uk.ORCID 0000-0003-2915-7119
University of Leeds · GB

Funding

Cancer Research UK 10066Cancer Research UK 17723Cancer Research UK 29212
6 · The paper itself

Abstract

The activated B-cell (ABC) to plasmablast transition encompasses the cusp of antibody-secreting cell (ASC) differentiation. We explore this transition with integrated analysis in human cells, focusing on changes that follow removal from CD40-mediated signals. Within hours of input signal loss, cell growth programs shift toward enhanced proliferation, accompanied by ER-stress response, and up-regulation of ASC features. Clustering of genomic occupancy for IRF4, BLIMP1, XBP1, and CTCF with histone marks identifies a dichotomy: XBP1 and IRF4 link to induced but not repressed gene modules in plasmablasts, whereas BLIMP1 links to modules of ABC genes that are repressed, but not to activated genes. Between ABC and plasmablast states, IRF4 shifts away from AP1/IRF composite elements while maintaining occupancy at IRF and ETS/IRF elements. This parallels the loss of

Indexed as

AdultB-LymphocytesCD40 AntigensCell DifferentiationCell ProliferationFemaleGene Regulatory NetworksHumansInterferon Regulatory Factor-4Interferon Regulatory FactorsLymphocyte ActivationMalePlasma CellsPositive Regulatory Domain I-Binding Factor 1Signal TransductionTranscriptional ActivationCD40 AntigensInterferon Regulatory Factor-4Interferon Regulatory FactorsPositive Regulatory Domain I-Binding Factor 1PRDM1 protein, humanX-Box Binding Protein 1XBP1 protein, human

Identifiers

PMID32843533
PMCPMC7471511
OpenAlexW3080823035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.